» Authors » John E Cannon

John E Cannon

Explore the profile of John E Cannon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 355
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Reddy S, Newman J, Leavy O, Ghani H, Pepke-Zaba J, Cannon J, et al.
Eur Respir J . 2024 Jul; 64(2. PMID: 39060016
Background: Pulmonary embolism (PE) is a well-recognised complication of coronavirus disease 2019 (COVID-19) infection, and chronic thromboembolic pulmonary disease with and without pulmonary hypertension (CTEPD/CTEPH) are potential life-limiting consequences. At...
2.
Kirkby L, Rodgers M, Amaral-Almeida L, Sheares K, Toshner M, Bunclark K, et al.
Pulm Circ . 2023 Jul; 13(3):e12265. PMID: 37415805
Pulmonary endarterectomy (PEA) may not achieve full clearance of vascular obstructions in patients with more distal chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) may be indicated to treat...
3.
Reddy S, Swietlik E, Robertson L, Michael A, Boyle S, Polwarth G, et al.
J Heart Lung Transplant . 2023 May; 42(9):1275-1285. PMID: 37201688
Background: We describe baseline characteristics, disease progression and mortality in chronic thromboembolic pulmonary disease patients as a function of mean pulmonary artery pressure (mPAP) according to new and previous definitions...
4.
Rodgers M, Kirkby L, Amaral-Almeida L, Sheares K, Toshner M, Taboada D, et al.
Pulm Circ . 2022 Dec; 12(4):e12166. PMID: 36568689
Acute lung injury (ALI) is a common but poorly defined and understood complication of balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH). Little data are available on the...
5.
Cannon J, Jenkins D, Hoole S
Expert Rev Cardiovasc Ther . 2022 Jan; 20(1):35-43. PMID: 35081846
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is an under-diagnosed complication of acute pulmonary embolism (PE), whereby there is incomplete resolution of pulmonary emboli, which then become organized into obstructive fibrotic...
6.
Bunclark K, Doughty N, Michael A, Abraham N, Ali S, Cannon J, et al.
Pulm Circ . 2021 Jun; 11(2):2045894021995055. PMID: 34104417
Several patient-reported outcome measures have been developed to assess health status in pulmonary arterial hypertension. The required change in instrument scores needed, to be seen as meaningful to the individual,...
7.
Swietlik E, Ghataorhe P, Zalewska K, Wharton J, Howard L, Taboada D, et al.
Eur Respir J . 2020 Oct; 57(4). PMID: 33060150
Pulmonary hypertension is a condition with limited effective treatment options. Chronic thromboembolic pulmonary hypertension (CTEPH) is a notable exception, with pulmonary endarterectomy (PEA) often proving curative. This study investigated the...
8.
Newnham M, Bunclark K, Abraham N, Ali S, Amaral-Almeida L, Cannon J, et al.
Eur Respir J . 2020 Jun; 56(4). PMID: 32513780
Background: Pulmonary endarterectomy (PEA) is the recommended treatment for eligible patients with chronic thromboembolic pulmonary hypertension (CTEPH). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) score is an internationally validated patient-reported...
9.
Hoole S, Coghlan J, Cannon J, Taboada D, Toshner M, Sheares K, et al.
Open Heart . 2020 Mar; 7(1):e001144. PMID: 32180986
Objective: Inoperable chronic thromboembolic pulmonary hypertension (CTEPH) managed medically has a poor prognosis. Balloon pulmonary angioplasty (BPA) offers a new treatment for inoperable patients. The national BPA service for the...
10.
Bunclark K, Newnham M, Chiu Y, Ruggiero A, Villar S, Cannon J, et al.
J Thromb Haemost . 2019 Sep; 18(1):114-122. PMID: 31557382
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon complication of acute pulmonary emboli necessitating lifelong anticoagulation. Despite this, few data exist on the safety and efficacy of vitamin K...